Search for: "Price v. Goldman" Results 321 - 340 of 375
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Jan 2013, 6:27 am by Gustavo Arballo
-- Buenos Aires, La Ley, 2012 Goldman, Diego Hernán; comp. , con prólogo de Bovino, Alberto. [read post]
23 May 2012, 8:29 am by Kevin LaCroix
Morgan, and Goldman Sachs, all cut their earnings forecasts and that news of the estimate cut was passed on only to a handful of large institutional clients, not to the public. [read post]
25 Apr 2020, 7:37 am by Francis Pileggi
Vice Chancellor Glasscock found evidence that several high-ranking Nuveen bond specialists warned Goldman Sachs, Deutsche Bank and J.P. [read post]
6 Aug 2014, 8:11 am by Eric Goldman
The reader is priced at $8 for a DRM-free PDF, which I think makes it quite student-friendly. [read post]
21 Dec 2011, 9:11 am by Max Kennerly, Esq.
They asked the Delaware Chancery Court to review the “entire fairness” of the transaction, per Kahn v. [read post]
5 Apr 2009, 1:26 pm
(Editor’s Note: This post is based on a client memorandum by Jonathan C. [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
10 Apr 2012, 10:33 am by Travis Crabtree
Professor Goldman in his Technology and Marketing Law Blog wrote: In this sense, the opinion reminded me of last week's Viacom v. [read post]
1 Jan 2023, 9:01 pm by Michael C. Dorf
” The 1969 Supreme Court decision in Powell v. [read post]
10 Apr 2012, 10:33 am by Travis Crabtree
Professor Goldman in his Technology and Marketing Law Blog wrote: In this sense, the opinion reminded me of last week's Viacom v. [read post]
1 May 2007, 1:06 am
Ware and co-conspirators at his firm, Rosenfeld, Goldman & Ware, were accused of issuing phony press releases to pump up the price of two stocks and then dumping the shares. [read post]
13 Jun 2008, 3:40 am
: (Patent Docs), Generic drug developers will continue to take advantage of global demand for lower-priced drugs, with Teva poised to maintain lead position says Goldman Sachs analyst: (GenericsWeb), Daiichi Sankyo takeover of Ranbaxy: (Profitability through Simplicity), (Spicy IP), (GenericsWeb), Canada: Generics to penetrate 26% pharma market in Canada says RNCOS research: (GenericsWeb), Canada: Generic drug makers spreading misinformation about patent regulation amendments to… [read post]
4 May 2013, 12:06 pm by Rebecca Tushnet
Board and copyright: some cases see price as a copyrightable opinion: CDN v. [read post]
11 Apr 2011, 5:14 am by Rebecca Tushnet
In congested circumstances, changing access price can enhance user value. [read post]